Education Hub

What Are Adaptogens? The Science Behind Ashwagandha, Rhodiola & Functional Mushrooms

Adaptogens are one of the most clinically-supported supplement categories — and one of the most misused terms in marketing. Here's what the science actually says.

Published 2026-06-01 · Updated 2026-06-09 · 9 min read

The short answer

Adaptogens are substances that help the body resist stress without disrupting normal function. The term was coined by Soviet researchers in the 1940s and has since been applied to ashwagandha, rhodiola, reishi, cordyceps, and others — all with clinical trial support. The catch: “adaptogen” is not a regulated term. Many products use it for marketing without the clinical dose or extract quality required for actual effect.

1947
Year the term "adaptogen" was coined by Lazarev; formalised by Brekhman in 1969
Brekhman & Dardymov
23
Botanicals currently classified as true adaptogens in peer-reviewed literature
Panossian, 2017
5–8 wks
Typical onset for measurable cortisol reduction in ashwagandha RCTs
Multiple RCTs
≥5%
Withanolide content required in ashwagandha for Cogniscore quality rating
Cogniscore methodology

The Three Criteria for a True Adaptogen

Soviet pharmacologist Israel Brekhman formalised the definition of an adaptogen in 1969. For a substance to qualify, it must meet three criteria:

  1. Non-specific: It must increase resistance to a broad range of stressors — physical, chemical, and biological — not just one specific type.
  2. Normalising: It must help restore the body toward homeostasis regardless of which direction the stressor has pushed it (reducing cortisol when elevated, supporting it when depleted).
  3. Non-toxic: It must cause minimal disruption to normal physiological function at therapeutic doses.

These three criteria exclude stimulants (which push the system in one direction), sedatives (which suppress rather than normalise), and many substances marketed as “adaptogens” that simply haven't been tested to these standards.

How Adaptogens Work: The HPA Axis

The primary pathway through which most adaptogens operate is the HPA axis — the hypothalamic-pituitary-adrenal system that governs the body's stress response. When stressed, the hypothalamus signals the pituitary, which signals the adrenal glands to release cortisol. Chronic stress leads to chronically elevated cortisol — which impairs memory, immune function, sleep, and metabolic health.

Ashwagandha withanolides, for example, have been shown to reduce serum cortisol by 14–30% in randomised controlled trials in chronically stressed adults. Rhodiola salidroside activates the stress-response protein Hsp70, which modulates the cortisol cascade before it reaches chronic elevation. Reishi triterpenes modulate cortisol through a different pathway — immune-adrenal crosstalk.

Adaptogen Comparison: Evidence and Dosing

AdaptogenPrimary MechanismClinical DoseExtract StandardEvidence
AshwagandhaHPA axis modulation, cortisol reduction300–600 mg/day≥5% withanolidesStrong (50+ RCTs)
Rhodiola RoseaFatigue resistance, mental performance200–600 mg/day≥3% rosavins, ≥1% salidrosideStrong (36+ RCTs)
ReishiImmune modulation, cortisol, sleep1,000–2,000 mg/day≥4% triterpenes + ≥20% beta-glucanModerate–Strong
CordycepsATP synthesis, physical stress resistance1,000–3,000 mg/day≥0.3% cordycepinModerate
EleutheroPhysical endurance, immune400–800 mg/day≥0.8% eleutherosidesModerate
SchisandraMental performance under stress, liver protection500–2,000 mg/day≥9% schisandrinsModerate

The Adaptogen Marketing Problem

“Adaptogen” is not a regulated term in the UK or EU. Any brand can label a product “adaptogenic” regardless of the dose or extract quality. Common practices that undermine efficacy:

  • Underdosing: Clinical ashwagandha trials use 300–600 mg of a ≥5% withanolide extract. Products with 50–100 mg of a non-standardised root powder will not produce the same effect.
  • Non-standardised extracts: “Ashwagandha root extract” without a withanolide percentage tells you nothing about potency.
  • Proprietary blends: When ashwagandha appears in a blend with 10 other ingredients and the total blend weight is 500 mg, the ashwagandha dose is almost certainly sub-clinical.
  • Misclassification: Some brands label turmeric, ginger, or green tea as “adaptogens.” These are not adaptogens by Brekhman's criteria.

Cogniscore scores adaptogen-containing products on extract standardisation and dose transparency. Products with standardised extracts at clinical dose ranges score significantly higher on the Disclosure dimension.

Adaptogen Questions Answered

What are adaptogens?+
Adaptogens are a class of botanical and fungal substances defined by three criteria, first formalised by Soviet pharmacologist Nikolai Lazarev in 1947 and later codified by Israel Brekhman: they must be non-specific (help the body resist a broad range of stressors, not just one), normalising (bring the body back toward equilibrium regardless of the direction of the stressor), and non-toxic at normal therapeutic doses. The term is now widely used in supplement marketing but should be applied only to substances with clinical evidence meeting these criteria.
Is ashwagandha an adaptogen?+
Yes. Ashwagandha (Withania somnifera) is one of the most well-studied adaptogens, with over 50 human clinical trials. Its primary mechanism is modulation of the HPA (hypothalamic-pituitary-adrenal) axis — the stress response system that governs cortisol release. Quality extracts standardised to ≥5% withanolides (KSM-66, Sensoril) consistently show reductions in cortisol, perceived stress scores, and anxiety measures in randomised controlled trials.
Is rhodiola an adaptogen?+
Yes. Rhodiola rosea is a well-evidenced adaptogen with particular evidence for mental fatigue, burnout, and physical performance. Its primary actives are rosavins and salidroside — both required in a quality extract (≥3% rosavins, ≥1% salidroside). Rhodiola is unusual in showing effects within days rather than weeks, making it one of the faster-acting adaptogens. The 3:1 rosavin-to-salidroside ratio reflects the natural root composition and is a quality marker.
Are mushrooms adaptogens?+
Some functional mushrooms meet the strict adaptogen criteria. Reishi (Ganoderma lucidum) is the most firmly categorised — its triterpenes modulate cortisol and immune function, meeting Brekhman's non-specific, normalising, non-toxic criteria. Cordyceps has adaptogenic properties for energy and physical stress resistance. Lion's mane is more accurately a nootropic (acting via NGF synthesis) than a traditional adaptogen, though it has stress-modulating effects. Not all mushrooms are adaptogens — classification requires clinical evidence.
How long do adaptogens take to work?+
It depends on the adaptogen and the outcome. Rhodiola rosea shows acute anti-fatigue effects within 1–3 days in some studies. Ashwagandha typically requires 4–8 weeks of consistent daily use for measurable cortisol reduction and stress-scale improvements. Reishi for immune modulation shows effects at 4 weeks. As a general rule: adaptogens are not immediate-acting supplements — their mechanism is regulatory, not stimulant.
Can you take multiple adaptogens at the same time?+
Yes, adaptogen stacking is common and generally safe. Many commercial 'mushroom blend' and 'adaptogen complex' products combine ashwagandha, rhodiola, reishi, and lion's mane. The main risk is not safety but under-dosing: blend products often distribute the total capsule weight across 6–8 ingredients, resulting in each individual ingredient being below its clinical dose threshold. Always check that each adaptogen in a blend is present at or near its minimum clinical dose.
What's the difference between an adaptogen and a nootropic?+
Adaptogens primarily work on the stress-response system (HPA axis, cortisol, immune resilience) — they help the body return to equilibrium under physical or psychological stress. Nootropics primarily target cognitive function: memory, focus, mental speed, and neuroplasticity. There is significant overlap — ashwagandha reduces cortisol which improves working memory; lion's mane supports NGF which is both neuroprotective and mildly adaptogenic. The categories are complementary, not mutually exclusive.

Sources & References

  • Brekhman II & Dardymov IV (1969). New substances of plant origin which increase non-specific resistance. Annual Review of Pharmacology.
  • Panossian A (2017). Understanding adaptogenic activity: specificity of the pharmacological action of adaptogens and other phytochemicals. Annals of the New York Academy of Sciences. PubMed
  • Chandrasekhar K et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety. Indian Journal of Psychological Medicine. PubMed
  • Shevtsov VA et al. (2003). A randomized trial of two different doses of Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine.
  • Cogniscore Brand Database (2026). Internal adaptogen extract standardisation review across 140+ products.